Your Article Summary
Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development
The Lancet Infectious Diseases, 06/24/09
Lo H et al. - Neisseria meningitidis remains an important cause of severe sepsis and meningitis worldwide. To date, available vaccines only protect individuals against subsets of meningococcal strains. However, two promising vaccines are currently being assessed in clinical trials and appear to offer good prospects for an effective means of protecting individuals against endemic serogroup B disease, which has proven to be a major challenge in vaccine research.
Related Articles
Absence of Neisseria meningitidis Serogroup C-Specific Antibodies during the First Year of Life in The Netherlands: an Age Group at Risk
Clinical and Vaccine Immunology, 10/06/09
Relevance Score: 85%
Prevalence and antimicrobial resistance pattern of bacterial meningitis in Egypt
Annals of Clinical Microbiology and Antimicrobials, 10/13/09
Relevance Score: 80%
Invasive meningococcal disease in Malta: an epidemiological overview, 1994–2007
Journal of Medical Microbiology, 10/21/09
Relevance Score: 77%
Today in CNS Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Dysregulated Epstein-Barr virus infection in patients with CIDP
Journal of Neuroimmunology, 12/04/09
Limited Role of CD4+Foxp3+ Regulatory T Cells in the Control of Experimental Cerebral Malaria
Journal of Immunology, 12/04/09
Infectious Encephalitis in France in 2007: A National Prospective Study
Clinical Infectious Diseases, 12/01/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
New England Journal of Medicine, 12/04/09
A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination
International Journal of Infectious Diseases, 12/04/09
Slowing Progression Along the Allergic Disease Continuum: Quo Vadit Immunotherapy
Pediatric Asthma, Allergy & Immunology, 12/04/09

See Latest Articles